Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...

In the optimistic missive, Washington extols the revolutionary spirit of the American people—even in defeat—and makes a rare ...

After a British attack on Danbury, Connecticut, Washington wrote the loss of supplies was trivial compared to the resistance by local militias.

In this article, James Kences documents the massive and dreadful die out of Indigenous people in the coastal areas of New ...

Nearly half of an elite U.S. epidemiology program known as the "disease detectives" were dismissed by the Trump ...

The "reappraisal of the Covid-19 epidemic" is heating things up. In order to bring more objectivity into the debate, "Krone" ...

The Trump administration's decision to dismiss nearly half of the Epidemic Intelligence Service raises serious concerns among ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...

Monday's report from USAID's inspector general says the food remains "at ports, in transit, and in warehouses at risk of spoilage, unanticipated storage needs, and diversion." The Trump administration ...

Health experts see his retreat from international cooperation as disrupting the safe-keepers of one of the world’s deadliest ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...